Effect of Intraoperative Volume Optimization on Outcome After Intrabdominal Surgery (EVOLUTION)

November 18, 2013 updated by: University Hospital, Lille

Effect of Intraoperative Volume Optimization on Outcome After Intrabdominal Surgery: a Multicenter, Randomized, Double-blind, Comparative Study

The purpose of this study is to determine whether intraoperative goal-directed fluid management (with goal = cardiac stroke volume maximization) based on respiratory-induced pulse pressure variation monitoring may improve outcome after intrabdominal surgery

Study Overview

Detailed Description

Recent studies strongly suggest that intraoperative oesophageal doppler guided fluid management may improve outcome after intrabdominal surgery. In these studies, however, the number of patients was often small, and management in control groups as well as postoperative complications were usually not precisely defined. In addition, widespread use of oesophageal doppler cannot be advocated in routine surgery, and the strategy necessitates repeated volume loading. This may lead to unnecessary intravenous fluids which may be deleterious, and intraoperative fluid restriction has also been shown to improve clinical outcome. In this context, indices reflecting the hemodynamic changes during mechanical ventilation (the so-called "dynamic indices", and more specifically the respiratory-induced pulse pressure variation) have been shown to accurately predict fluid responsiveness in mechanically ventilated patients. Automated and continuous calculation of pulse pressure variation variation from standard peripheral (typically radial) arterial line has recently been validated. This study was thus designed to determine whether intraoperative goal-directed fluid management (with goal = cardiac stroke volume maximization) based on pulse pressure variation monitoring would improve outcome after intrabdominal surgery.

Study Type

Interventional

Enrollment (Actual)

104

Phase

  • Phase 4

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

      • Amiens, France, 80054
        • University Hospital
      • Caen, France, 14033
        • University Hospital
      • Clermont-ferrand, France, 63000
        • Département d'Anesthésie-Réanimation, Hôpital Estaing, CHU
      • Créteil, France, 94010
        • University hospital Henri-Mondor
      • Lille, France, 59000
        • University Hospital
      • Rouen, France, 76031
        • University Hospital

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years and older (Adult, Older Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • major elective intrabdominal surgery

Exclusion Criteria:

  • arrhythmia
  • hepatectomy
  • associated thoracic surgery
  • laparoscopy
  • pregnancy
  • allergy to colloid solution or anesthesia protocol
  • arterial catheter not possible

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Triple

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Optimization
volume optimization: continuous monitoring of the respiratory-induced arterial pulse pressure variation during surgery and systematic minimization to 10% or less by volume loading

Fluid management:

  • basal fluid administration = 5 ml/kg/h lactated Ringer's solution

    + systematic minimization of the arterial pulse pressure variation (PPV) to 10% or less by volume loading (6% hydroxyethyl starch) throughout surgery

  • hypovolemia suspected : fluids (1. crystalloids, 2. 6% hydroxyethyl starch) only if PPV is > 10%
Other Names:
  • preload optimization
Active Comparator: control; standard volume administration
standard volume administration

Fluid management:

  • basal fluid administration = 5 ml/kg/h lactated Ringer's solution
  • hypovolemia suspected : fluids (1. crystalloids, 2. 6% hydroxyethyl starch) according to predetermined algorithm primarily based on mean arterial pressure, heart rate, and urine output, and secondary on PPV
Other Names:
  • fluid compensation

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Time Frame
Total number of patients with complications
Time Frame: first 7 postoperative days
first 7 postoperative days

Secondary Outcome Measures

Outcome Measure
Time Frame
total number of complications
Time Frame: first 7 postoperative days
first 7 postoperative days
SOFA (Sequential Organ Failure Assessment) score
Time Frame: postoperative days 1 and 5
postoperative days 1 and 5
Time to initial passage of flatus and feces
Time Frame: postoperative
postoperative
duration of stay in intensive care unit
Time Frame: postoperative
postoperative
Duration of hospital stay
Time Frame: postoperative
postoperative
death
Time Frame: in-hospital and postoperative day 28
in-hospital and postoperative day 28
volumes of fluid administered
Time Frame: duration of surgery
duration of surgery

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Study Director: Benoit TAVERNIER, MD, PhD, University Hospital, Lille
  • Principal Investigator: Benoit VALLET, MD, PhD, University Hospital, Lille

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start

February 1, 2009

Primary Completion (Actual)

April 1, 2013

Study Completion (Actual)

April 1, 2013

Study Registration Dates

First Submitted

October 3, 2008

First Submitted That Met QC Criteria

October 3, 2008

First Posted (Estimate)

October 6, 2008

Study Record Updates

Last Update Posted (Estimate)

November 19, 2013

Last Update Submitted That Met QC Criteria

November 18, 2013

Last Verified

November 1, 2013

More Information

Terms related to this study

Other Study ID Numbers

  • 2007-A01436-47
  • PHRC 2006/1915 (Other Identifier: DHOS)
  • 2007/0723 (Other Identifier: sponsor)

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Surgery

Clinical Trials on volume optimization

3
Subscribe